User profiles for T. Chou

Tsu-Wei Chou

- Verified email at udel.edu - Cited by 51563

Ting-Chao Chou

- Verified email at PDScience.org - Cited by 43653

Drug combination studies and their synergy quantification using the Chou-Talalay method

TC Chou - Cancer research, 2010 - AACR
… Its applications were greatly facilitated by the help of Joseph Chou, who developed the
first-generation computer software for dose-effect analysis based on the “mass-action law” (14). …

Advances in the science and technology of carbon nanotubes and their composites: a review

ET Thostenson, Z Ren, TW Chou - Composites science and technology, 2001 - Elsevier
Since their first observation nearly a decade ago by Iijima (Iijima S. Helical microtubules of
graphitic carbon Nature. 1991; 354:56–8), carbon nanotubes have been the focus of …

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

TC Chou, P Talalay - Advances in enzyme regulation, 1984 - Elsevier
… obtained by Yonetani and TheoreU (55) and Chou and Talalay (59) using different methods…
TC CHOU, On the determination of availability of ligand binding sites in steady-state systems…

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

TC Chou - Pharmacological reviews, 2006 - ASPET
… More importantly, it is shown that K i /I 50 = E x /E t , where E t is the total amount of enzyme
and E x is the fractional availability of the enzyme species with which the inhibitor may …

[PDF][PDF] Neuregulin 1 and susceptibility to schizophrenia

…, S Gunnarsdottir, O Ivarsson, TT Chou… - The American Journal of …, 2002 - cell.com
The cause of schizophrenia is unknown, but it has a significant genetic component.
Pharmacologic studies, studies of gene expression in man, and studies of mouse mutants suggest …

The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells

…, S Zaccara, D Nguyen, G Minuesa, T Chou, A Chow… - Nature medicine, 2017 - nature.com
N 6 -methyladenosine (m 6 A) is an abundant nucleotide modification in mRNA that is
required for the differentiation of mouse embryonic stem cells. However, it remains unknown …

A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City

…, N Abou-Fayssal, P Krieger, A Lewis, AS Lord, T Zhou… - Neurology, 2021 - AAN Enterprises
Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

…, AC Truax, MC Micsenyi, TT Chou, J Bruce, T Schuck… - Science, 2006 - science.org
Ubiquitin-positive, tau- and α-synuclein–negative inclusions are hallmarks of frontotemporal
lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. …

Determination of earthquake source parameters from waveform data for studies of global and regional seismicity

AM Dziewonski, TA Chou… - Journal of Geophysical …, 1981 - Wiley Online Library
It is possible to use the waveform data not only to derive the source mechanism of an earthquake
but also to establish the hypocentral coordinates of the ‘best point source’ (the centroid …

Nanocomposites in context

ET Thostenson, C Li, TW Chou - Composites science and technology, 2005 - Elsevier
This paper provides an overview of recent advances in nanocomposites research. The key
research opportunities and challenges in the development of structural and functional …